Platelet-derived microparticles during and after acute coronary syndrome.
about
Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and ThrombosisThe significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smokingAnalysis of Extracellular Vesicles Using Magnetic Nanoparticles in Blood of Patients with Acute Coronary SyndromeDo platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?Small but mighty: microparticles as mediators of tumor progression.Central role of eNOS in the maintenance of endothelial homeostasisThe diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants.A Meta-Analysis of Circulating Microvesicles in Patients with Myocardial Infarction.Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?Dietary flavanol intervention lowers the levels of endothelial microparticles in coronary artery disease patients.Platelet-Derived Microvesicles in Cardiovascular Diseases.The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles.Endothelial damage effects of circulating microparticles from patients with stable angina are reduced by aspirin through ERK/p38 MAPKs pathways.Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.Flow analysis of individual blood extracellular vesicles in acute coronary syndrome.Cardiac rehabilitation programme as a non-pharmacological platelet inhibitory tool in acute coronary syndrome survivors.Small platelet microparticle levels are increased in pulmonary arterial hypertension.
P2860
Q28069254-89A82FD8-4098-4E84-A86E-7E54BEEF04E3Q36723994-8438E13D-E3BF-413E-85E6-38633EE27D9DQ37138303-DEF006C1-67F7-4F9F-B9B6-CA4940B8231CQ37732309-DF9E2ABF-28AA-4BE4-B133-7751C82520ADQ38202537-16FA4FF8-69BC-467F-A8E8-4C27BC48A645Q38261420-A086C256-A723-409C-8458-F2AA438FB366Q38624868-8283167C-5BB1-4123-BB02-57960B84DF11Q39159683-9EF74F55-EFFF-4232-9A73-238DE042973EQ39626663-945A8A33-8932-4226-81D3-59D0681D4350Q41556597-CC96E625-BD8C-4C20-BD04-6F5CEB198704Q45807873-48C3D449-FFCF-4650-BE86-95FC99C2AD66Q45981560-D0605221-049A-4445-A2F5-559694A6C61CQ47106708-23FA78D0-C36F-4888-AA84-56BF5C3EA592Q47159100-6BE26A90-06A5-49F7-B7FE-F50D06B694D4Q48127018-6605BE45-5A0B-4F8F-96F4-EE771DD90A96Q49741768-BA9723A7-24E2-4346-9B83-B27B0782F7E2Q50319342-128ABAEC-7A3A-4A39-9245-7BD41741622EQ52672007-07B21CD2-A515-46CE-8DFA-F79390051AEBQ54469933-4C919A40-DCB7-417D-A93A-9CA0216E0DEC
P2860
Platelet-derived microparticles during and after acute coronary syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Platelet-derived microparticles during and after acute coronary syndrome.
@en
Platelet-derived microparticles during and after acute coronary syndrome.
@nl
type
label
Platelet-derived microparticles during and after acute coronary syndrome.
@en
Platelet-derived microparticles during and after acute coronary syndrome.
@nl
prefLabel
Platelet-derived microparticles during and after acute coronary syndrome.
@en
Platelet-derived microparticles during and after acute coronary syndrome.
@nl
P356
P1476
Platelet-derived microparticles during and after acute coronary syndrome.
@en
P2093
Karin Malmqvist
Mika Skeppholm
P304
P356
10.1160/TH11-11-0779
P577
2012-02-28T00:00:00Z